Literature DB >> 11327151

The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly.

L C Walker1, H LeVine.   

Abstract

The abnormal assembly and deposition of specific proteins in the brain is the probable cause of most neurodegenerative disease afflicting the elderly. These "cerebral proteopathies" include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), prion diseases, and a variety of other disorders. Evidence is accumulating that the anomalous aggregation of the proteins, and not a loss of protein function, is central to the pathogenesis of these diseases. Thus, therapeutic strategies that reduce the production, accumulation, or polymerization of pathogenic proteins might be applicable to a wide range of some of the most devastating diseases of old age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11327151     DOI: 10.1385/MN:21:1-2:083

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  79 in total

1.  Screening for pharmacologic inhibitors of amyloid fibril formation.

Authors:  H LeVine; J D Scholten
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease.

Authors:  I Vincent; J H Zheng; D W Dickson; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  1998 Jul-Aug       Impact factor: 4.673

3.  Familial Presenile Dementia with Spastic Paralysis.

Authors:  C Worster-Drought; T R Hill; W H McMenemey
Journal:  J Neurol Psychopathol       Date:  1933-07

Review 4.  A beta amyloidogenesis: unique, or variation on a systemic theme?

Authors:  R Kisilevsky; P E Fraser
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

5.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

7.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

8.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

Authors:  J Janson; R H Ashley; D Harrison; S McIntyre; P C Butler
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

Review 9.  REVIEW: tau protein pathology in Alzheimer's disease and related disorders.

Authors:  M Tolnay; A Probst
Journal:  Neuropathol Appl Neurobiol       Date:  1999-06       Impact factor: 8.090

Review 10.  Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses.

Authors:  D C Gajdusek
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

View more
  19 in total

1.  Mosaic aging.

Authors:  Lary C Walker; James G Herndon
Journal:  Med Hypotheses       Date:  2010-01-27       Impact factor: 1.538

2.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

Review 3.  Immune activation in brain aging and neurodegeneration: too much or too little?

Authors:  Kurt M Lucin; Tony Wyss-Coray
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 4.  Corruption and spread of pathogenic proteins in neurodegenerative diseases.

Authors:  Lary C Walker; Harry LeVine
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

Review 5.  Targeting heat shock proteins to modulate α-synuclein toxicity.

Authors:  Daryl Rhys Jones; Simon Moussaud; Pamela McLean
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

6.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

Review 7.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

Review 8.  Emerging New Concepts of Degrader Technologies.

Authors:  Yu Ding; Yiyan Fei; Boxun Lu
Journal:  Trends Pharmacol Sci       Date:  2020-04-23       Impact factor: 14.819

9.  Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein.

Authors:  Georg Künze; Patrick Barré; Holger A Scheidt; Lars Thomas; David Eliezer; Daniel Huster
Journal:  Biochim Biophys Acta       Date:  2012-04-06

Review 10.  Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.

Authors:  Kwadwo A Opoku-Nsiah; Jason E Gestwicki
Journal:  Transl Res       Date:  2018-06-19       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.